HVC
VIRX

Healthcare Value Capital’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Healthcare Value Capital’s Portfolio VIRX Stock Details VIRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-4,286
Closed -$543K – 23
2016
Q4 		$543K Hold
4,286
– – 0.58% 18
2016
Q3 		$656K Buy
4,286
+3,572
+500% +$504K 1.04% 16
2016
Q2 		$82K Hold
714
– – 0.1% 26
2016
Q1 		$81K Hold
714
– – 0.12% 30
2015
Q4 		$135K Sell
714
-1,429
-67% -$267K 0.22% 21
2015
Q3 		$365K Sell
2,143
-1,190
-36% -$429K 0.52% 24
2015
Q2 		$2.11M Buy
3,333
+2,381
+250% +$1.27M 2.21% 15
2015
Q1 		$490K Buy
+952
New +$480K 0.53% 30
2014
Q4 		– Sell
-476
Closed -$714K – 33
2014
Q3 		$714K Sell
476
-238
-33% -$345K 0.69% 22
2014
Q2 		$978K Buy
714
+476
+200% +$552K 0.82% 21
2014
Q1 		$331K Buy
+238
New +$277K 0.22% 44

Other funds holding VIRX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Healthcare Value Capital's VIRX Position: Q3 2015 in Review

Healthcare Value Capital sold out of Viracta Therapeutics, Inc. Common Stock (VIRX) in Q3 2015, closing a stake of 952 shares — an estimated $343K sold.

Healthcare Value Capital first reported a position in VIRX in Q2 2013 and held it in 8 quarters. The position peaked at $682K in Q1 2014. 59 funds tracked by Wall St. Rank hold VIRX as of Q3 2015.

  • Healthcare Value Capital reported no remaining Viracta Therapeutics, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
  • Healthcare Value Capital sold 952 Viracta Therapeutics, Inc. Common Stock shares in Q3 2015, an estimated $343K.
  • Healthcare Value Capital first reported a position in Viracta Therapeutics, Inc. Common Stock in Q2 2013 and held it in 8 quarters.
  • Healthcare Value Capital's Viracta Therapeutics, Inc. Common Stock position peaked at $682K in Q1 2014.
  • 59 funds tracked by Wall St. Rank held Viracta Therapeutics, Inc. Common Stock as of Q3 2015.

Based on Healthcare Value Capital's 13F filing for Q3 2015, filed 16 Nov 2015.